Journal of Neurology

, Volume 262, Issue 1, pp 239–242 | Cite as

Acute stroke management

  • E. C. Tallantyre
  • N. P. RobertsonEmail author
Journal club

Stroke disease is the second leading cause of death in the world. Even if stroke incidence remains stable, the number of new acute strokes in Europe is projected to increase markedly by 2025. In 2007, the SITS-MOST trial provided the first conclusive evidence that intravenous thrombolysis with recombinant tissue plasminogen activator (rTPA) was beneficial in the acute period for patients with cerebral infarct. Evidence from the same year showed that decompressive hemicraniectomy can double the rate of survival with a favourable outcome for young patients with malignant middle-cerebral artery infarct. These studies and others from that period altered the landscape of stroke management dramatically. Reperfusion has become a central component of acute stroke strategy and neurosurgical intervention for acute stroke has become commonplace in many European centres.

In this month’s journal club, we review three papers which aim to refine or expand our current use of acute interventions for...


Acute Stroke Stroke Onset Intravenous Thrombolysis Acute Cerebral Infarction Modify Rankin Score 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Clinical NeurologyUniversity Hospital of WalesCardiffUK
  2. 2.Department of Neurology, Institute of Psychological Medicine and Clinical NeuroscienceCardiff UniversityCardiffUK

Personalised recommendations